127 related articles for article (PubMed ID: 22728103)
1. Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome.
Vidal V; García S; Martínez P; Corrales A; Flórez J; Rueda N; Sharma A; Martínez-Cué C
Neuroscience; 2012 Sep; 220():158-68. PubMed ID: 22728103
[TBL] [Abstract][Full Text] [Related]
2. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
3. Kcnj6(GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome.
Joshi K; Shen L; Cao F; Dong S; Jia Z; Cortez MA; Snead OC
Epilepsy Res; 2018 Sep; 145():82-88. PubMed ID: 29929098
[TBL] [Abstract][Full Text] [Related]
4. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
[TBL] [Abstract][Full Text] [Related]
5. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current.
Best TK; Siarey RJ; Galdzicki Z
J Neurophysiol; 2007 Jan; 97(1):892-900. PubMed ID: 17093127
[TBL] [Abstract][Full Text] [Related]
6. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome.
Corrales A; Martínez P; García S; Vidal V; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
J Pineal Res; 2013 Apr; 54(3):346-58. PubMed ID: 23350971
[TBL] [Abstract][Full Text] [Related]
7. Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel.
Joshi K; Shen L; Michaeli A; Salter M; Thibault-Messier G; Hashmi S; Eubanks JH; Cortez MA; Snead OC
Ann Neurol; 2016 Oct; 80(4):511-21. PubMed ID: 27462820
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels.
Kobayashi T; Hirai H; Iino M; Fuse I; Mitsumura K; Washiyama K; Kasai S; Ikeda K
Neuropharmacology; 2009 Feb; 56(2):499-506. PubMed ID: 18977371
[TBL] [Abstract][Full Text] [Related]
9. Isobolographic and behavioral characterizations of interactions between vigabatrin and gabapentin in two experimental models of epilepsy.
Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Eur J Pharmacol; 2008 Oct; 595(1-3):13-21. PubMed ID: 18708046
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin, A GABA analogue, enhances cognitive performance in mice.
Celikyurt IK; Mutlu O; Ulak G; Akar FY; Erden F
Neurosci Lett; 2011 Apr; 492(2):124-8. PubMed ID: 21296127
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Behav Brain Res; 2008 Apr; 188(2):355-67. PubMed ID: 18178265
[TBL] [Abstract][Full Text] [Related]
12. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
[TBL] [Abstract][Full Text] [Related]
13. Effect of gabapentin on cognitive processes in rats not exposed and exposed to tobacco smoke during fetal life.
Czubak A; Nowakowska E; Kus K; Sadowski C; Matschay A
Hum Exp Toxicol; 2008 Dec; 27(12):883-94. PubMed ID: 19273543
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined treatment with diuretics and gabapentin on convulsive threshold in mice.
Łukawski K; Swiderska G; Czuczwar SJ
Acta Pol Pharm; 2013; 70(1):147-52. PubMed ID: 23610970
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
[TBL] [Abstract][Full Text] [Related]
16. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
[TBL] [Abstract][Full Text] [Related]
17. Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.
Llorens-Martín MV; Rueda N; Tejeda GS; Flórez J; Trejo JL; Martínez-Cué C
Neuroscience; 2010 Dec; 171(4):1228-40. PubMed ID: 20875841
[TBL] [Abstract][Full Text] [Related]
18. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome.
Corrales A; Vidal R; García S; Vidal V; Martínez P; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
J Pineal Res; 2014 Jan; 56(1):51-61. PubMed ID: 24147912
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic administration of ethosuximide on learning and memory: a behavioral and biochemical study on nonepileptic rats.
Ponnusamy R; Pradhan N
Behav Pharmacol; 2006 Nov; 17(7):573-80. PubMed ID: 17021389
[TBL] [Abstract][Full Text] [Related]
20. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
